Aktienanalyse zu Avantor, Inc. (AVTR)AVTRAvantor, Inc.

Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company's segments include Bioscience & Medtech Products and VWR Distribution & Services. Through these segments, it provides materials and consumables, equipment and instrumentation and services and specialty procurement to customers in biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and others. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Avantor Inc is a good buy right now due to its current price of $16.42, which is below the analyst price targets of $15 to $17, suggesting upside potential. The stock has shown a strong year-to-date change of +43.28%, indicating positive momentum. However, the company has faced challenges with a negative net income in Q3 2025, which is a risk to consider.